How are SLS cash-secured put max profit and max loss calculated?

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the SLS cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 239.50%), the computed maximum profit is $395.00 per contract and the computed maximum loss is -$1,004.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a SLS cash-secured put?

The breakeven for the SLS cash-secured put priced on this page is roughly $10.05 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SLS market-implied 1-standard-deviation expected move is approximately 68.66%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current SLS implied volatility affect this cash-secured put?

SLS ATM IV is at 239.50% with IV rank near 66.09%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

SLS Cash-Secured Put Strategy

SLS (SELLAS Life Sciences Group, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009; and Memorial Sloan Kettering Cancer Center for developing and commercializing MSK's WT1 peptide vaccine technology. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.

SLS (SELLAS Life Sciences Group, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $2.30B, a beta of 2.53 versus the broader market, a 52-week range of 1.39-12.43, average daily share volume of 7.8M, a public-listing history dating back to 2008, approximately 13 full-time employees. These structural characteristics shape how SLS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 2.53 indicates SLS has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a cash-secured put on SLS?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

Current SLS snapshot

As of June 30, 2026, spot at $14.75, ATM IV 239.50%, IV rank 66.09%, expected move 68.66%. The cash-secured put on SLS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 31-day expiry.

Why this cash-secured put structure on SLS specifically: SLS IV at 239.50% is mid-range versus its 1-year history, so the credit collected on a SLS cash-secured put sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 68.66% (roughly $10.13 on the underlying). The 31-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SLS expiries trade a higher absolute premium for lower per-day decay. Position sizing on SLS should anchor to the underlying notional of $14.75 per share and to the trader's directional view on SLS stock.

SLS cash-secured put setup

The SLS cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SLS near $14.75, the first option leg uses a $14.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SLS chain at a 31-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SLS shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Sell 1	Put	$14.00	$3.95

SLS cash-secured put risk and reward

Net Premium / Debit: +$395.00
Max Profit (per contract): $395.00
Max Loss (per contract): -$1,004.00
Breakeven(s): $10.05
Risk / Reward Ratio: 0.393

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

SLS cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on SLS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-99.9%	-$1,004.00
$3.27	-77.8%	-$677.98
$6.53	-55.7%	-$351.96
$9.79	-33.6%	-$25.94
$13.05	-11.5%	+$300.08
$16.31	+10.6%	+$395.00
$19.57	+32.7%	+$395.00
$22.83	+54.8%	+$395.00
$26.09	+76.9%	+$395.00
$29.35	+99.0%	+$395.00

When traders use cash-secured put on SLS

Cash-secured puts on SLS earn premium while a trader waits to acquire SLS stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning SLS.

SLS thesis for this cash-secured put

The market-implied 1-standard-deviation range for SLS extends from approximately $4.62 on the downside to $24.88 on the upside. A SLS cash-secured put lets a trader earn premium while waiting to acquire SLS at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current SLS IV rank near 66.09% is mid-range against its 1-year distribution, so the IV signal is neutral; the cash-secured put thesis on SLS should anchor more to the directional view and the expected-move geometry. As a Healthcare name, SLS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SLS-specific events.

SLS cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SLS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SLS alongside the broader basket even when SLS-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on SLS carry tail risk when realized volatility exceeds the implied move; review historical SLS earnings reactions and macro stress periods before sizing. Always rebuild the position from current SLS chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on SLS?: A cash-secured put on SLS is the cash-secured put strategy applied to SLS (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With SLS stock trading near $14.75, the strikes shown on this page are snapped to the nearest listed SLS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are SLS cash-secured put max profit and max loss calculated?: Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the SLS cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 239.50%), the computed maximum profit is $395.00 per contract and the computed maximum loss is -$1,004.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a SLS cash-secured put?: The breakeven for the SLS cash-secured put priced on this page is roughly $10.05 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SLS market-implied 1-standard-deviation expected move is approximately 68.66%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on SLS?: Cash-secured puts on SLS earn premium while a trader waits to acquire SLS stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning SLS.
How does current SLS implied volatility affect this cash-secured put?: SLS ATM IV is at 239.50% with IV rank near 66.09%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.